<DOC>
	<DOCNO>NCT02077621</DOCNO>
	<brief_summary>PG2 approve Taiwan treat cancer-related fatigue advance cancer patient . The primary objective study evaluate efficacy PG2 fatigue relief patient undergo palliative abdominal surgery cancer . The secondary endpoint , include length hospital stay , postoperative complication , HRQL , inflammatory biomarkers , duration antibiotic therapy , mortality hospital stay , weight loss body composition , evaluate among patient .</brief_summary>
	<brief_title>Study PG2 Injection Improving Fatigue Patients After Palliative Abdominal Surgery Cancer</brief_title>
	<detailed_description>This double-blind , randomize , placebo-controlled study . At least 40 evaluable patient schedule palliative abdominal surgery cancer randomly assign control treatment group . Each group least 20 patient treated follow : 1 ) control group : patient accept placebo 1 dose day ( POD-1 ) surgery 1 dose day 3 day surgery ( POD+0 POD+2 ) ; 2 ) treatment group : patient accept PG2 1 dose day ( POD-1 ) surgery 1 dose day 3 day surgery ( POD+0 POD+2 ) .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Patients cancer schedule palliative abdominal surgery cancer Age &gt; 20 year old Patients sign informed consent form Patients , screen , level great 2.5 time upper limit normal liver function alanine aminotransferase aspartate aminotransferase . Patients severe renal impairment ( define serum creatinine great 2 time upper limit normal BUN great 2.5 time upper limit normal range ) ; subject dialysis . Patients ongoing infection , respiratory tract dysfunction , cardiac dysfunction immune disorder , opinion investigator , may interfere conduct study . Patients suitable undergoing surgery ( e.g . congenital hemostatic disorder ) investigator 's judgment . Patients enrol yet complete investigational drug trial within 1 month screening . Female patient pregnant breastfeeding . Patients require preoperative nutritional support Patients serious comorbidities ( American Society Anesthesiologists Risk Class 4 5 ) . Patients unwilling unable answer quality life questionnaires i.e . BFIT EORTC QLQC30 .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cancer-related fatigue</keyword>
	<keyword>Palliative Abdominal Surgery</keyword>
	<keyword>HRQL</keyword>
</DOC>